Wellgistics Health (NASDAQ: WGRX) Launches XRP Payment Program for Independent Pharmacies
Wellgistics Health (NASDAQ:WGRX) has launched an innovative XRP Implementation Program enabling blockchain-based payments for independent pharmacies. The program, developed in partnership with RxERP, allows 6,500+ independent pharmacies and 200+ manufacturers to process instant, low-cost transactions using XRP technology.
The platform offers key benefits including instant settlement, reduced fees, 24/7 availability, improved cash flow, and real-time tracking. The system integrates with RxERP's pharmaceutical eCommerce platform and complies with HIPAA and AML requirements.
Following the initial pharmacy rollout, Wellgistics plans to expand the program to include manufacturer onboarding and Direct-to-Patient (DTP) programs, enabling direct medication shipments to patients' homes while maintaining clinical oversight.
Wellgistics Health (NASDAQ:WGRX) ha lanciato un innovativo Programma di Implementazione XRP che abilita pagamenti basati su blockchain per le farmacie indipendenti. Il programma, sviluppato in collaborazione con RxERP, permette a oltre 6.500 farmacie indipendenti e a più di 200 produttori di effettuare transazioni istantanee e a basso costo utilizzando la tecnologia XRP.
La piattaforma offre vantaggi chiave come regolamento istantaneo, riduzione delle commissioni, disponibilità 24/7, miglioramento del flusso di cassa e tracciamento in tempo reale. Il sistema si integra con la piattaforma di eCommerce farmaceutico di RxERP e rispetta i requisiti HIPAA e AML.
Dopo il primo rollout nelle farmacie, Wellgistics prevede di estendere il programma all'onboarding dei produttori e ai programmi Direct-to-Patient (DTP), permettendo spedizioni dirette dei farmaci a domicilio dei pazienti mantenendo la supervisione clinica.
Wellgistics Health (NASDAQ:WGRX) ha lanzado un innovador Programa de Implementación de XRP que permite pagos basados en blockchain para farmacias independientes. El programa, desarrollado en colaboración con RxERP, permite que más de 6.500 farmacias independientes y más de 200 fabricantes procesen transacciones instantáneas y de bajo coste usando la tecnología XRP.
La plataforma ofrece beneficios clave como liquidación instantánea, reducción de tarifas, disponibilidad 24/7, mejora del flujo de efectivo y seguimiento en tiempo real. El sistema se integra con la plataforma de comercio electrónico farmacéutico de RxERP y cumple con los requisitos HIPAA y AML.
Tras el despliegue inicial en farmacias, Wellgistics planea ampliar el programa para incluir la incorporación de fabricantes y los programas Direct-to-Patient (DTP), permitiendo envíos directos de medicamentos al domicilio de los pacientes manteniendo la supervisión clínica.
Wellgistics Health (NASDAQ:WGRX)는 독립 약국을 위한 블록체인 기반 결제를 가능하게 하는 혁신적인 XRP 도입 프로그램을 시작했습니다. RxERP와 협력해 개발된 이 프로그램은 6,500개 이상의 독립 약국과 200개 이상의 제조업체가 XRP 기술을 이용해 즉시 처리되고 저비용인 거래를 수행할 수 있도록 합니다.
플랫폼은 즉시 정산, 수수료 감소, 24/7 이용 가능, 현금 흐름 개선 및 실시간 추적 등 주요 이점을 제공합니다. 시스템은 RxERP의 의약품 전자상거래 플랫폼과 통합되며 HIPAA 및 자금세탁방지(AML) 규정을 준수합니다.
초기 약국 도입 이후 Wellgistics는 제조업체 온보딩과 Direct-to-Patient(DTP) 프로그램을 포함하도록 프로그램을 확장할 계획이며, 임상 감독을 유지하면서 환자 자택으로 약품을 직접 배송할 수 있게 됩니다.
Wellgistics Health (NASDAQ:WGRX) a lancé un programme d'implémentation XRP innovant permettant des paiements basés sur la blockchain pour les pharmacies indépendantes. Le programme, développé en partenariat avec RxERP, permet à plus de 6 500 pharmacies indépendantes et à plus de 200 fabricants de traiter des transactions instantanées et peu coûteuses grâce à la technologie XRP.
La plateforme offre des avantages clés tels que le règlement instantané, la réduction des frais, une disponibilité 24/7, l'amélioration des flux de trésorerie et le suivi en temps réel. Le système s'intègre à la plateforme e-commerce pharmaceutique de RxERP et se conforme aux exigences HIPAA et AML.
Après le déploiement initial auprès des pharmacies, Wellgistics prévoit d'étendre le programme à l'intégration des fabricants et aux programmes Direct-to-Patient (DTP), permettant l'envoi direct de médicaments au domicile des patients tout en maintenant la supervision clinique.
Wellgistics Health (NASDAQ:WGRX) hat ein innovatives XRP-Implementierungsprogramm gestartet, das blockchain-basierte Zahlungen für unabhängige Apotheken ermöglicht. Das Programm, in Zusammenarbeit mit RxERP entwickelt, erlaubt es mehr als 6.500 unabhängigen Apotheken und über 200 Herstellern, sofortige, kostengünstige Transaktionen mithilfe der XRP-Technologie abzuwickeln.
Die Plattform bietet wichtige Vorteile wie sofortige Abrechnung, geringere Gebühren, 24/7-Verfügbarkeit, verbesserte Liquidität und Echtzeit-Tracking. Das System lässt sich in die eCommerce-Plattform von RxERP für den Pharmabereich integrieren und erfüllt HIPAA- sowie AML-Anforderungen.
Nach dem ersten Rollout bei Apotheken plant Wellgistics, das Programm auf die Einbindung von Herstellern und Direct-to-Patient-(DTP)-Programme auszuweiten, wodurch Medikamente direkt an die Patienten nach Hause versandt werden können, bei gleichzeitiger Beibehaltung der klinischen Aufsicht.
- First healthcare company to implement XRP-based payment solution at scale
- Serves over 6,500 independent pharmacies and 200 manufacturers nationwide
- Instant payment settlement and reduced transaction costs compared to traditional methods
- Platform complies with HIPAA and AML requirements while maintaining security
- Currently in beta phase with limited initial functionality
- Success depends on pharmacy adoption and willingness to switch from traditional payment methods
Insights
Wellgistics Health's XRP payment system brings blockchain efficiency to pharmacy operations, potentially reducing costs and improving cash flow for 6,500+ independent pharmacies.
Wellgistics Health's XRP Implementation Program represents a significant technological leap for pharmaceutical distribution by integrating Ripple's blockchain technology into pharmacy payment systems. By enabling instant settlements, the platform addresses a critical pain point for independent pharmacies that typically face multi-day delays and substantial fees when processing transactions through traditional banking channels.
The technological architecture leveraging the XRP Ledger offers three key advantages: transaction processing in seconds rather than days, substantially lower processing fees compared to credit card networks, and 24/7 availability that eliminates banking hours constraints. For the 6,500+ independent pharmacies in Wellgistics' network, this translates to improved cash flow management and inventory control—fundamental operational concerns in the low-margin pharmacy business.
The integration with RxERP for onboarding and transaction management shows a thoughtful implementation approach that addresses both the technical and practical aspects of blockchain adoption in healthcare. The phased rollout strategy—starting with pharmacy payments before expanding to manufacturer onboarding and eventually direct-to-patient programs—demonstrates a measured approach to ecosystem development.
What's particularly notable is that this implementation extends beyond proof-of-concept to a full-scale operational system, rare in healthcare blockchain applications where many initiatives remain theoretical. The regulatory compliance considerations, including HIPAA and AML requirements, address the complex compliance landscape that has historically slowed blockchain adoption in healthcare settings.
Wellgistics' XRP payment system could significantly improve margins by reducing transaction costs while expanding its market position among 6,500+ pharmacies.
Wellgistics Health's XRP payment initiative represents a strategic expansion of their value proposition in the pharmaceutical distribution space. By tackling payment inefficiencies, the company is addressing a significant operational cost center for independent pharmacies, which typically operate on thin margins of 2-3% where transaction fees can materially impact profitability.
From a business model perspective, this positions Wellgistics beyond traditional pharmaceutical distribution into the fintech space. The company already has significant market penetration with 6,500+ independent pharmacies and 200+ manufacturers nationwide, providing a substantial built-in market for this new payment solution. The network effect could be powerful—as more pharmacies and eventually manufacturers adopt the platform, its utility and value proposition strengthen.
What's particularly compelling is the potential impact on Wellgistics' own financial performance. While not explicitly stated, the company likely benefits from either transaction fees (albeit lower than traditional methods) or enhanced customer retention and increased transaction volume. The elimination of intermediaries suggests improved margins on pharmaceutical distribution by reducing payment processing costs.
The phased approach to implementation—starting with pharmacy payments before expanding to manufacturers and direct-to-patient programs—indicates a well-considered scaling strategy. Each phase creates additional revenue opportunities and deepens the company's entrenchment in the pharmaceutical supply chain. The partnership with RxERP further solidifies the technical infrastructure, creating additional barriers to competitive entry.
TAMPA, FLORIDA / ACCESS Newswire / August 13, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the launch of its Ripple Labs-powered XRP Implementation Program, giving independent pharmacies access to blockchain-based payments in the prescription drug space for the first time. The program enables pharmacies to pay for products and move funds instantly, more cost-effectively, and with full transparency-eliminating delays, high fees, and reliance on traditional banking and credit card networks. Wellgistics Health is among the first healthcare companies to implement an XRP-based payment solution at scale.
The program operates in partnership with RxERP, a serialized pharmaceutical eCommerce and ERP (Enterprise Resource Planning) system that manages onboarding, transactions, and reporting for participating pharmacies. With Wellgistics already serving more than 6,500 independent pharmacies and over 200 manufacturers nationwide, the Company is well-positioned to accelerate adoption rapidly and at scale.
Pharmacies can now enroll in the beta program at:
https://wellgisticshealth.com/xrp-in-healthcare/
How Pharmacies Benefit from Using XRP
Instant Settlement - Payments settle in seconds, not days
Lower Fees - Avoid credit card and bank transaction costs
24/7 Availability - No banking delays, even on weekends and holidays
Improved Cash Flow - Faster access to working capital and inventory restock
Real-Time Tracking - View and confirm payments instantly
No Intermediaries - Direct transactions between pharmacy and distributor
"We've been impressed with the response so far," said Brian Norton, CEO of Wellgistics Health. "Independent pharmacy owners are far more forward-thinking than many realize. They see the power of blockchain and understand how transformative this will be as it scales across the industry. Our mission is to give pharmacies greater control, speed, and transparency in their financial operations."
Technical Innovation and Blockchain Integration
The XRP Payment Program harnesses the speed, scalability, and low-cost infrastructure of the XRP Ledger to meet the unique demands of the pharmaceutical supply chain. Integrated with RxERP, the platform delivers real-time, encrypted, and fully compliant payment processing tailored for independent pharmacies, wholesalers and in the near future, manufacturers.
Pharmacies and investors can learn more by downloading the Wellgistics Health XRP E-Book:
https://wellgisticshealth.com/xrp-in-healthcare/
Regulatory Compliance and Security
The XRP Payment Program has been developed to meet or exceed healthcare and financial regulatory standards, including HIPAA and anti-money laundering (AML) requirements. The system provides secure, traceable transactions while safeguarding sensitive data and maintaining privacy at every stage.
Next Phase: Manufacturer Onboarding and Direct-to-Patient (DTP) Programs
Following the pharmacy rollout, Wellgistics Health will begin onboarding pharmaceutical manufacturers to the XRP platform-expanding capabilities for direct, on-chain transactions. The Company also plans to launch manufacturer-powered Direct-to-Patient (DTP) programs, allowing manufacturers to ship medications directly to patients' homes in collaboration with their community pharmacy and prescribing physicians to ensure clinical continuity and compliance.
"Pharmacies deserve a payment system as fast and responsive as the care they provide," said Tony Madsen, COO of Wellgistics Health. "While this first phase focuses on helping pharmacies pay for products more efficiently, it's just the start. Our vision is to make every aspect of pharmacy payments faster, clearer, and completely frictionless."
About Wellgistics Health
Wellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufacturers, providing wholesale distribution, digital prescription routing, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health offers compliant, end-to-end solutions that restore access, transparency, and trust in U.S. healthcare.
About RxERP
RxERP is the only serialized pharmaceutical ERP system designed specifically for independent pharmacies, wholesalers, and manufacturers. It delivers real-time financial, operational, and compliance tools-integrating blockchain, AI, and serialized inventory management to streamline operations and modernize the supply chain. RxERP is the platform partner managing the XRP Implementation Program with Wellgistics Health.
Forward-Looking Statements
This press release may contain forward-looking statements regarding Wellgistics Health's plans, strategies, future operations, and expected performance. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that could affect these results include, but are not limited to, market conditions and risks detailed in filings with the SEC. Investors are cautioned not to place undue reliance on forward-looking statements. Additional information is available at www.sec.gov.
Media Contact: media@wellgisticshealth.com
Investor Relations: investors@wellgisticshealth.com
Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, NY 10036
Office: (646) 893-5835
Email: info@skylineccg.com
SOURCE: Wellgistics Health, Inc.
View the original press release on ACCESS Newswire
FAQ
What is Wellgistics Health's (WGRX) new XRP Payment Program?
How does the WGRX XRP payment system benefit pharmacies?
When will Wellgistics Health expand the XRP program to manufacturers?
Is Wellgistics Health's XRP payment platform compliant with healthcare regulations?
How many pharmacies and manufacturers does Wellgistics Health serve?
